| |
Medical Hypotheses, Vol. 59, No. 5. (November 2002), pp. 537-551.
|
| |
Neuroscience, Vol. 112, No. 2. (2002), pp. 243-260.
|
| |
Medical hypotheses, Vol. 40, No. 3. (March 1993), pp. 174-181.
|
| |
N Engl J Med, Vol. 359, No. 21. (20 November 2008), pp. 2195-2207.
by Paul M. Ridker, Eleanor Danielson, Francisco A. H. Fonseca, et al.Jacques Genest, Antonio M. Gotto, John J. P. Kastelein, Wolfgang Koenig, Peter Libby, Alberto J. Lorenzatti, Jean G. MacFadyen, Borge G. Nordestgaard, James Shepherd, James T. Willerson, Robert J. Glynn, the JUPITER Study Group
|
| |
European Journal of Clinical Nutrition, Vol. aop, No. current.
|
| |
QJM, Vol. 96, No. 12. (1 December 2003), pp. 927-934.
|
| |
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital, Vol. 34, No. 1. (2007), pp. 11-18.
|
| |
American Heart Journal, Vol. 152, No. 6. (December 2006), pp. 1077-1083.
|
| |
Current Atherosclerosis Reports, Vol. 8, No. 5. (2006), pp. 405-411.
|
| |
Am J Physiol Regul Integr Comp Physiol, Vol. 285, No. 5. (1 November 2003), pp. R1253-1256.
|
| |
Scandinavian journal of clinical and laboratory investigation. Supplementum, Vol. 226 (1996), pp. 9-17.
|
| |
Journal of clinical microbiology, Vol. 43, No. 1. (January 2005), pp. 19-24.
|
| |
Clinical microbiology reviews, Vol. 15, No. 1. (January 2002), pp. 1-20.
|
| |
Antimicrob. Agents Chemother., Vol. 48, No. 4. (1 April 2004), pp. 1402-1405.
|
| |
Antimicrob. Agents Chemother., Vol. 47, No. 6. (1 June 2003), pp. 1972-1975.
|
| |
International Congress Series, Vol. 1262 (May 2004), pp. 430-433.
|
| |
FEMS microbiology letters, Vol. 242, No. 2. (15 January 2005), pp. 203-208.
|
| |
Circulation, Vol. 103, No. 3. (23 January 2001), pp. 351-356.
|